Clinical Trial Update: XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating XELOX with Cadonilimab versus XELOX alone as neoadjuvant therapy for locally advanced, mismatch repair proficient rectal cancer; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Cadonilimab
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Rectal Cancer, MSS | Phase 2 | Status: UNKNOWN